<DOC>
	<DOCNO>NCT01898078</DOCNO>
	<brief_summary>This open-label , multicenter , phase 1 study primary objective evaluate effect food single-dose PK property alisertib administer ECT formulation . The secondary objective evaluate safety tolerability alisertib .</brief_summary>
	<brief_title>Food Effect Study Alisertib ( MLN8237 ) Patients With Advanced Solid Tumors Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>18 year old Histologically cytologically confirm advanced tumor lymphomas standard curative lifeprolonging treatment exist , longer effective tolerable Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Patient must meet protocolspecified laboratory value Female patient postmenopausal least 1 year OR surgically sterile OR childbearing potential , agree practice 2 effective method contraception time agree practice true abstinence Male patient agree practice effective barrier contraception entire study 4 month last dose study drug OR agree practice true abstinence Prior current investigational therapy within 4 week first dose alisertib Female patient lactate pregnant Patient require treatment clinically significant enzyme inducer , enzymeinducing antiepileptic drug phenytoin , carbamazepine , phenobarbital , rifampin , rifabutin , rifapentine , St. John 's wort within 14 day first dose alisertib study Medical condition require daily , chronic , regular use proton pump inhibitor ( PPIs ) within 7 day precede first dose alisertib , H2receptor antagonists Patient require systemic anticoagulation Ongoing nausea vomit Grade 2 bad intensity Known GI disease GI procedure could interfere oral absorption , excretion , tolerance alisertib History uncontrolled sleep apnea syndrome condition could result excessive daytime sleepiness severe chronic obstructive pulmonary disease Known suspect human immunodeficiency virus ( HIV ) positive hepatitis B surface antigenpositive status , know suspect active hepatitis C infection Patients lactoseintolerant unwilling/unable consume protocol specify standardized highfat breakfast Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>MLN8237</keyword>
	<keyword>alisertib</keyword>
	<keyword>food effect</keyword>
</DOC>